Products

ReachSocial

AI-native

Grow your LinkedIn on autopilot

ingagenow.co Marketing / Social Account Growth

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$99/mo
Higher than 94% of peersNiche median $14.99/mo
Creators
Clifton Sellers
@cliftonsellers· 362.8K followers+1 more creators
Launched
19mo ago
2025-04-28 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
X accounts@cliftonsellers
  • Launched on Product HuntLaunch

    Build LinkedIn influence with AI-driven organic engagement

    Apr 28, 2025 · 19mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-01-16

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Get started for
$99/mo
Unlimited scheduling and publishing

Trial: Every new ReachSocial account starts with a 7-day free trial. · 1 paid tier ($99) · Observed 2026-11-10 · Source page

Entry price $99/mo, Higher than 94% of peers; “Social Account Growth” median is $14.99/mo.View pricing benchmark

Website snapshots

Indexed 2025-04-28

Key pages

Desktop & mobile archive
Home
reachsocial.ai/ Snapshot 2026-11-10

Questions & evidence

How much does ReachSocial cost?
Get started for: $99/mo. Observed 2026-11-10. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does ReachSocial get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ReachSocial and what platforms does it support?
ReachSocial is catalogued under Social Account Growth: Grow your LinkedIn on autopilot. Supported platforms: Web.

Related products in this category

Marketing / Social Account Growth

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.